MX2017005419A - Tratamiento o prevencion de anemia en mamiferos no humanos preñados. - Google Patents
Tratamiento o prevencion de anemia en mamiferos no humanos preñados.Info
- Publication number
- MX2017005419A MX2017005419A MX2017005419A MX2017005419A MX2017005419A MX 2017005419 A MX2017005419 A MX 2017005419A MX 2017005419 A MX2017005419 A MX 2017005419A MX 2017005419 A MX2017005419 A MX 2017005419A MX 2017005419 A MX2017005419 A MX 2017005419A
- Authority
- MX
- Mexico
- Prior art keywords
- human mammal
- blood haemoglobin
- pregnant non
- increasing
- less
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se relaciona con un complejo de hierro carbohidrato para su uso en un método para incrementar la concentración de hemoglobina sanguínea en un mamífero no humano preñado, en donde al mamífero no humano preñado que tiene un nivel de hemoglobina sanguínea de 105 g/L o menos, se administra una o más dosis de complejo de hierro carbohidrato que comprende una cantidad de hierro elemental de 1800 mg o más por dosis. El método se relaciona con los efectos adicionales de la reducción de crías mortinatas de un mamífero no humano preñado que tiene un nivel de hemoglobina sanguínea de 105 g/L o menos, el incremento de la concentración de hemoglobina sanguínea de las camadas de cría dentro de 3 días desde el nacimiento y/o el destete, o el incremento del tamaño de la camada en una paridad subsiguiente de un mamífero no humano que tiene un nivel de hemoglobina sanguínea de 105 g/L o menos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201470654 | 2014-10-27 | ||
| PCT/DK2015/050328 WO2016066172A1 (en) | 2014-10-27 | 2015-10-27 | Treatment or prevention of anaemia in pregnant non-human mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017005419A true MX2017005419A (es) | 2017-11-30 |
Family
ID=54360839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017005419A MX2017005419A (es) | 2014-10-27 | 2015-10-27 | Tratamiento o prevencion de anemia en mamiferos no humanos preñados. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11040059B2 (es) |
| EP (2) | EP3212182B1 (es) |
| JP (1) | JP6680777B2 (es) |
| CN (3) | CN107206017B (es) |
| BR (1) | BR112017008709A2 (es) |
| CA (1) | CA2965722C (es) |
| DK (1) | DK3212182T3 (es) |
| ES (1) | ES2743223T3 (es) |
| HU (1) | HUE045092T2 (es) |
| LT (1) | LT3212182T (es) |
| MX (1) | MX2017005419A (es) |
| PH (1) | PH12017500646A1 (es) |
| PL (1) | PL3212182T3 (es) |
| PT (1) | PT3212182T (es) |
| RS (1) | RS59240B1 (es) |
| RU (1) | RU2712211C2 (es) |
| WO (1) | WO2016066172A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11040059B2 (en) * | 2014-10-27 | 2021-06-22 | Pharmacosmos Holding A/S | Treatment or prevention of anaemia in pregnant non-human mammals |
| CA3029576A1 (en) * | 2016-06-30 | 2018-01-04 | Victoria C. KENNEDY | Method for improving the quality and quantity of offspring in mammals |
| KR20200044030A (ko) | 2017-09-11 | 2020-04-28 | 파르마코스모스 홀딩 에이/에스 | 치료용 철 착화합물 |
| JP2022505697A (ja) * | 2018-10-29 | 2022-01-14 | ファーマコスモス ホールディング エー／エス | カルボキシマルトース第二鉄による鉄欠乏症の治療 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3105791A (en) * | 1961-07-20 | 1963-10-01 | Richardson Merrell Inc | Method of preventing the development of iron deficiency anemia in suckling pigs |
| US3259500A (en) * | 1961-10-11 | 1966-07-05 | Kentucky Res Foundation | Method for inhibiting anemia in young pigs by feeding the sow an iron agent |
| US4076803A (en) | 1976-03-15 | 1978-02-28 | Ashmead H H | Synergistic combination of metal proteinates with beta-chlorovinyl dialkyl phosphates |
| DK172860B1 (da) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| WO2002085134A1 (en) * | 2001-04-24 | 2002-10-31 | Lonza Ltd. | Method of enhancing reproductive performance in sows |
| RU2274003C2 (ru) | 2004-03-02 | 2006-04-20 | Станислав Людвигович Люблинский | Способ комплексной переработки крови сельскохозяйственных животных для получения биологически активного вещества с противоанемическими свойствами на основе гемоглобина, биологически активное вещество с противоанемическими свойствами (варианты) и продукт, его содержащий (варианты). |
| DE102007054794A1 (de) | 2007-11-13 | 2009-05-14 | Agilan Gmbh | Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen |
| CA2756580A1 (en) * | 2009-03-25 | 2010-09-30 | Hans Andreasen | A stable iron oligosaccharide compound |
| PL2959916T3 (pl) | 2011-02-17 | 2019-05-31 | Boehringer Ingelheim Vetmedica Gmbh | Nowy europejski szczep prrsv |
| US11040059B2 (en) * | 2014-10-27 | 2021-06-22 | Pharmacosmos Holding A/S | Treatment or prevention of anaemia in pregnant non-human mammals |
-
2015
- 2015-10-27 US US15/522,466 patent/US11040059B2/en active Active
- 2015-10-27 CN CN201580058214.7A patent/CN107206017B/zh active Active
- 2015-10-27 CN CN202110410139.3A patent/CN113559115A/zh active Pending
- 2015-10-27 RU RU2017118319A patent/RU2712211C2/ru active
- 2015-10-27 RS RSP20190966 patent/RS59240B1/sr unknown
- 2015-10-27 EP EP15787128.6A patent/EP3212182B1/en active Active
- 2015-10-27 BR BR112017008709A patent/BR112017008709A2/pt not_active Application Discontinuation
- 2015-10-27 LT LTEP15787128.6T patent/LT3212182T/lt unknown
- 2015-10-27 PT PT15787128T patent/PT3212182T/pt unknown
- 2015-10-27 CN CN202110407403.8A patent/CN113476471A/zh active Pending
- 2015-10-27 CA CA2965722A patent/CA2965722C/en active Active
- 2015-10-27 WO PCT/DK2015/050328 patent/WO2016066172A1/en active Application Filing
- 2015-10-27 HU HUE15787128A patent/HUE045092T2/hu unknown
- 2015-10-27 JP JP2017522471A patent/JP6680777B2/ja active Active
- 2015-10-27 EP EP19181718.8A patent/EP3603632A1/en active Pending
- 2015-10-27 MX MX2017005419A patent/MX2017005419A/es active IP Right Grant
- 2015-10-27 ES ES15787128T patent/ES2743223T3/es active Active
- 2015-10-27 DK DK15787128.6T patent/DK3212182T3/da active
- 2015-10-27 PL PL15787128T patent/PL3212182T3/pl unknown
-
2017
- 2017-04-06 PH PH12017500646A patent/PH12017500646A1/en unknown
-
2021
- 2021-03-15 US US17/201,110 patent/US20210369763A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK3212182T3 (da) | 2019-08-05 |
| RU2712211C2 (ru) | 2020-01-27 |
| PL3212182T3 (pl) | 2019-12-31 |
| CN107206017A (zh) | 2017-09-26 |
| CN113476471A (zh) | 2021-10-08 |
| RS59240B1 (sr) | 2019-10-31 |
| LT3212182T (lt) | 2019-10-10 |
| EP3603632A1 (en) | 2020-02-05 |
| US20210369763A1 (en) | 2021-12-02 |
| JP2017535537A (ja) | 2017-11-30 |
| RU2017118319A3 (es) | 2019-06-17 |
| EP3212182A1 (en) | 2017-09-06 |
| CN107206017B (zh) | 2021-05-07 |
| CN113559115A (zh) | 2021-10-29 |
| JP6680777B2 (ja) | 2020-04-15 |
| CA2965722A1 (en) | 2016-05-06 |
| RU2017118319A (ru) | 2018-11-29 |
| US20170333470A1 (en) | 2017-11-23 |
| WO2016066172A1 (en) | 2016-05-06 |
| CA2965722C (en) | 2023-02-14 |
| HUE045092T2 (hu) | 2019-12-30 |
| EP3212182B1 (en) | 2019-06-26 |
| BR112017008709A2 (pt) | 2017-12-26 |
| PH12017500646A1 (en) | 2017-09-25 |
| ES2743223T3 (es) | 2020-02-18 |
| US11040059B2 (en) | 2021-06-22 |
| PT3212182T (pt) | 2019-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017500646A1 (en) | Treatment or prevention of anaemia in pregnant non-human mammals | |
| PH12016500773A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section | |
| PH12016500762A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | |
| PH12018501325A1 (en) | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion | |
| PH12017502079A1 (en) | Treatment of beta-thalassemia using actrii ligand traps | |
| MX2016006060A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. | |
| NZ612504A (en) | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents | |
| JP2015529083A5 (es) | ||
| PH12019501010A1 (en) | Arginase inhibitor combination therapies | |
| MX2016004441A (es) | Tratamiento del cancer con una combinacion de plinabulina y taxano. | |
| JOP20190008A1 (ar) | علاج ومنع اضطرابات النوم | |
| GB201205739D0 (en) | Treatment of acute inflammation in the respiratory tract | |
| JP2016519107A5 (es) | ||
| PH12019500092A1 (en) | Nutritional compositions for infants and/or young children comprising oligosaccharides | |
| PH12017500617A1 (en) | Dosage regimen for pegylated interferon | |
| ECSP19000167A (es) | Métodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis | |
| MX2017010011A (es) | Metodos para aumentar las caracteristicas de rendimiento en crias. | |
| Cockerill | Gemcitabine/mitomycin | |
| Carpenter | Bruising: case report | |
| Markhorst | Headache: case report | |
| Folger | Ulcerative oesophagitis: case report | |
| Mrlian et al. | Brain tissue oxygen directed management and outcome in the patients with severe traumatic brain injury | |
| Yamada | Tracheal fistula: case report | |
| 丁勇 | Effects of maternal exposure to nano-alumina during pregnancy on neurodevelopment in offspring mice | |
| Gross | Bevacizumab/docetaxel/everolimus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |